Shire Human Genetic Therapies Inc.
GPTKB entity
Properties (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
gptkb:Shire_plc
|
| gptkbp:clinicalTrials |
ongoing
|
| gptkbp:employees |
approximately 1,000
|
| gptkbp:focus |
genetic therapies
|
| gptkbp:founded |
2008
|
| gptkbp:headquarters |
gptkb:Lexington,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Shire Human Genetic Therapies Inc.
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:location |
gptkb:United_States
|
| gptkbp:parentCompany |
gptkb:Shire_plc
|
| gptkbp:partnerships |
various academic institutions
|
| gptkbp:products |
gptkb:Glybera
Duchenne_muscular_dystrophy_treatments |
| gptkbp:regulatoryCompliance |
FDA_approved
|
| gptkbp:researchFocus |
rare diseases
|
| gptkbp:services |
gene therapy
|
| gptkbp:website |
www.shire.com
|